Evidence map›Paper›PMID 40814435›Full record

ArticleNeuro-oncology practice2025

Advance care planning in primary malignant brain tumors: Knowledge, experiences, and preferences of patients and caregivers.

Ai Chikada, Yoshiki Arakawa, Sayaka Takenouchi, Yoshitaka Narita

Abstract read
In one paragraph

Article in Neuro-oncology practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ai ChikadaHuman Health Sciences, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.ORCID https://orcid.org/0000-0001-9310-0745
Yoshiki ArakawaDepartment of Neurosurgery, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan.ORCID https://orcid.org/0000-0003-4626-4645
Sayaka TakenouchiHuman Health Sciences, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.
Yoshitaka NaritaDepartment of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.ORCID https://orcid.org/0000-0003-4303-6006

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Advance care planning (ACP) can help patients with primary malignant brain tumors to align treatments with their preferences. However, insights into patients' and caregivers' engagement with ACP remain scarce. This study elaborates on their knowledge, experiences, and preferences concerning ACP. Methods: This was a secondary analysis of data from the "National Survey on the Needs and Support of Brain Tumor Patients and Caregivers" in Japan. Responses from 128 patients and 106 caregivers were included. Descriptive statistics, logistic regression, and qualitative analyses of free-text responses were performed. Results: Patients were more willing than caregivers to participate in decisions regarding their treatment (96.8% vs. 82.5%, Conclusions: The mismatch between respondents' willingness to participate in ACP and their knowledge and experience reveals a need to increase ACP awareness. Differences in ACP preferences between patients and their caregivers may indicate the need for improved communication strategies by healthcare professionals. Further research is needed to understand these differences.

Indexed as

advance care planningcaregiverdecision-makingpatient engagementprimary malignant brain tumors

Identifiers

PMID40814435
PMCPMC12349760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.